BVF Inc
- SEC CIK
- 0001056807
- 最新申報
- 2026/8/14
2022 年第 4 季持倉
持倉截至 2022/12/31，2023/2/14 申報。只含多頭部位，變化是跟 2022 年第 3 季比股數。
- 持股檔數
- 78
- 較 2022 年第 3 季 −2
- 總值
- $23.7 億
- 較 2022 年第 3 季 −$5,136 萬 (−2.1%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 21,751,284 | $2.28 億 | 9.6% | 00.0% | 不變 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 1,755,000 | $1.35 億 | 5.7% | +1,755,000 | 新進 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 8,291,988 | $1.22 億 | 5.1% | 00.0% | 不變 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 4,692,604 | $1.17 億 | 4.9% | 00.0% | 不變 | 歷史 |
| GHRSGH Research PLC | ORDINARY SHARES | 9,275,158 | $8,969 萬 | 3.8% | 00.0% | 不變 | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 4,007,413 | $8,900 萬 | 3.8% | 00.0% | 不變 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 7,509,059 | $7,922 萬 | 3.3% | 00.0% | 不變 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 3,255,588 | $7,755 萬 | 3.3% | 00.0% | 不變 | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 9,177,748 | $6,691 萬 | 2.8% | +3,587,700+64.2% | 加碼 | 歷史 |
| XOMAXOMA Royalty Corp | COM NEW | 3,611,494 | $6,645 萬 | 2.8% | 00.0% | 不變 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 3,876,021 | $5,791 萬 | 2.4% | −463,500−10.7% | 減碼 | 歷史 |
| CTICCti Biopharma Corp | COM | 8,813,021 | $5,297 萬 | 2.2% | 00.0% | 不變 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 3,276,543 | $5,161 萬 | 2.2% | −700,000−17.6% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 1,271,243 | $5,013 萬 | 2.1% | +370,148+41.1% | 加碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 2,736,613 | $5,008 萬 | 2.1% | −942,334−25.6% | 減碼 | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 2,303,520 | $4,764 萬 | 2.0% | −413,500−15.2% | 減碼 | 歷史 |
| KURAKura Oncology, Inc. | COM | 3,800,983 | $4,717 萬 | 2.0% | +597,200+18.6% | 加碼 | 歷史 |
| ZYMEZymeworks Inc. | COM | 5,870,000 | $4,614 萬 | 1.9% | +5,870,000 | 新進 | 歷史 |
| MRUSMerus N.V. | COM | 2,978,420 | $4,608 萬 | 1.9% | −466,000−13.5% | 減碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 2,561,000 | $4,546 萬 | 1.9% | +2,561,000 | 新進 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 1,121,809 | $4,237 萬 | 1.8% | −1,751,144−61.0% | 減碼 | 歷史 |
| ALLKAllakos Inc. | COM | 5,006,921 | $4,216 萬 | 1.8% | 00.0% | 不變 | 歷史 |
| REPLReplimune Group, Inc. | COM | 1,522,629 | $4,142 萬 | 1.7% | +596,100+64.3% | 加碼 | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,205,089 | $4,007 萬 | 1.7% | −1,089,770−33.1% | 減碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 1,451,197 | $3,693 萬 | 1.6% | −346,888−19.3% | 減碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 1,238,974 | $3,619 萬 | 1.5% | −502,866−28.9% | 減碼 | 歷史 |
| ITOSiTeos Therapeutics, Inc. | COM | 1,810,835 | $3,537 萬 | 1.5% | 00.0% | 不變 | 歷史 |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 16,149,179 | $3,084 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| CBIOCrescent Biopharma, Inc. | COM | 9,544,262 | $2,892 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| Rain Oncology Inc.75082Q105 | COM | 3,526,729 | $2,821 萬 | 1.2% | 00.0% | 不變 | – |
| STROSutro Biopharma, Inc. | COM | 3,347,946 | $2,705 萬 | 1.1% | −100,000−2.9% | 減碼 | 歷史 |
| SLNSilence Therapeutics plc | ADS | 1,508,416 | $2,300 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| VIGLVigil Neuroscience, Inc. | COM | 1,813,633 | $2,267 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 8,748,629 | $2,205 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 6,894,345 | $2,137 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| CNCEConcert Pharmaceuticals, Inc. | COM | 3,629,000 | $2,119 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| ANNXAnnexon, Inc. | COM | 3,780,694 | $1,955 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 1,470,334 | $1,936 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| TYRATyra Biosciences, Inc. | COM | 2,472,327 | $1,879 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| THRDThird Harmonic Bio, Inc. | COM | 4,365,933 | $1,877 萬 | 0.8% | +864,119+24.7% | 加碼 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 7,611,503 | $1,865 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 1,521,948 | $1,601 萬 | 0.7% | +1,521,948 | 新進 | 歷史 |
| ACIUAC Immune SA | SHS | 7,428,379 | $1,515 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| ANTXAN2 Therapeutics, Inc. | COM | 1,563,963 | $1,490 萬 | 0.6% | −52,702−3.3% | 減碼 | 歷史 |
| Calliditas Therapeutics AB13124Q106 | SPONSERED ADS | 750,000 | $1,315 萬 | 0.6% | 00.0% | 不變 | – |
| OVIDOvid Therapeutics Inc. | COM | 6,851,051 | $1,274 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| VERVVerve Therapeutics, Inc. | COM | 650,000 | $1,258 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 984,824 | $1,138 萬 | 0.5% | −1,100,000−52.8% | 減碼 | 歷史 |
| CTMXCytomX Therapeutics, Inc. | COM | 6,595,801 | $1,055 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 1,135,940 | $834.9 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| VSTMVerastem, Inc. | COM | 19,022,656 | $765.7 萬 | 0.3% | −952,002−4.8% | 減碼 | 歷史 |
| NLS Pharmaceutics LtdH57830103 | SHS | 5,747,126 | $741.4 萬 | 0.3% | +5,747,126 | 新進 | – |
| WHWKWhitehawk Therapeutics, Inc. | COM | 562,309 | $721.4 萬 | 0.3% | −316,776−36.0% | 減碼 | 歷史 |
| IMAImageneBio, Inc. | COM | 2,503,071 | $665.8 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ARAVAravive, Inc. | COM | 4,784,214 | $631.5 萬 | 0.3% | +4,784,214 | 新進 | 歷史 |
| ELDNEledon Pharmaceuticals, Inc. | COM | 2,326,710 | $539.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| Pieris Pharmaceuticals Inc720795103 | COM | 5,080,320 | $528.4 萬 | 0.2% | 00.0% | 不變 | – |
| VIRXViracta Therapeutics, Inc. | COM | 3,614,662 | $527.7 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CDTXCidara Therapeutics, Inc. | COM | 6,861,127 | $518.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 100,000 | $443.8 萬 | 0.2% | +100,000 | 新進 | 歷史 |
| HLVXHilleVax, Inc. | COM | 248,579 | $415.9 萬 | 0.2% | −133,873−35.0% | 減碼 | 歷史 |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 2,938,851 | $393.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| INFIInfinity Pharmaceuticals, Inc. | COM | 6,353,645 | $352.6 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| IVAInventiva S.A. | ADS | 686,040 | $303.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| MOLNMolecular Partners AG | ADS | 443,221 | $287.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ELEVElevation Acquisition Group Inc. | COM | 2,312,200 | $219.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| MTEMMolecular Templates, Inc. | COM | 4,996,565 | $163.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| IMUXImmunic, Inc. | COM | 1,149,425 | $160.9 萬 | 0.1% | +1,149,425 | 新進 | 歷史 |
| RNACCartesian Therapeutics, Inc. | COM | 1,391,749 | $157.3 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CALACalithera Biosciences, Inc. | COM NEW | 464,742 | $151.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| XFORX4 Pharmaceuticals, Inc | COM | 1,347,650 | $133.8 萬 | 0.1% | +499,771+58.9% | 加碼 | 歷史 |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 1,370,947 | $116.5 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| EOCNGalmed Pharmaceuticals Ltd. | SHS | 1,739,670 | $87.0 萬 | <0.1% | −60,024−3.3% | 減碼 | 歷史 |
| ELTXElicio Therapeutics, Inc. | COM | 1,071,297 | $86.9 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| RNTXRein Therapeutics, Inc. | COM NEW | 236,835 | $56.1 萬 | <0.1% | −26,443−10.0% | 減碼依 1 比 20 拆股換算 | 歷史 |
| GBIOGeneration Bio Co. | COM | 102,900 | $40.4 萬 | <0.1% | −258,924−71.6% | 減碼 | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 190,815 | $39.5 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| BNOXBionomics Ltd | ADS | 80,971 | $37.3 萬 | <0.1% | 00.0% | 不變 | 歷史 |
2022 年第 3 季之後清倉（10 檔）
2022 年第 3 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2022 年第 3 季股數 | 2022 年第 3 季市值 | 2022 年第 3 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| RLMDRelmada Therapeutics, Inc. | COM | 2,078,220 | $7,694 萬 | 3.2% | 歷史 |
| CINCCinCor Pharma, Inc. | COM | 1,312,443 | $4,307 萬 | 1.8% | 歷史 |
| NUVLNuvalent, Inc. | COM | 1,666,282 | $3,239 萬 | 1.3% | 歷史 |
| EQRXEQRx, Inc. | COM | 6,008,187 | $2,974 萬 | 1.2% | 歷史 |
| ETNB89bio, Inc. | COM | 3,143,682 | $1,820 萬 | 0.8% | 歷史 |
| SPROSpero Therapeutics, Inc. | COM | 1,929,376 | $385.9 萬 | 0.2% | 歷史 |
| Forward Pharma A/S34986J204 | SPONSORD ADS NEW | 513,791 | $151.6 萬 | 0.1% | – |
| LITSLite Strategy, Inc. | COM NEW | 3,532,057 | $136.5 萬 | 0.1% | 歷史 |
| Erytech Pharma29604W108 | SPONSORED ADR | 1,314,656 | $69.0 萬 | <0.1% | – |
| CFRXCONTRAFECT Corp | COM NEW | 472,300 | $7.90 萬 | <0.1% | 歷史 |